Oxnard, CA, December 2017 – FOMAT Medical Research, a leading organization in clinical research, is launching a joint venture with Reumalab in order to provide clinical research services in Medellin, Colombia, that is set to improve clinical research outcomes in Latin…
5 ways to boost Minorities’ Participation in Clinical Trials
Minorities’ participation in clinical trials is often an issue of debate among the clinical research industry. Anyway, most of us agree that their participation is crucial in order to develop better treatments for everybody. That’s why as part of the professionals…
Hispanics and Diabetes Clinical Studies
Hispanics and Diabetes People with Hispanic or Latino backgrounds are at higher risk for developing type 2 diabetes than non-Hispanic Caucasians. This is a fact that researchers have long known. However, most research has looked at this group as a whole,…
Why diversity in Clinical trials is important?
Understanding the issue Clinical trials are the key to find and learn about the consequences of new medical treatments in people’s well-being. Some of them focus on patient’s safety and treatment effectiveness, others are just observational. These treatments include medicines, medical…
Marketing Strategies in Clinical Trials
It’s no secret that the recruitment process is often the most difficult part for a clinical trial. Just to give an example, let’s analyze a report from the Pharmaceutical Technology website. The report states that 15 – 20% of trials never…
Ministry of Health admits new regulation for Clinical Research in Peru
Friday, June 30, 2017, after two years, MINSA has issued a new regulation of clinical studies, through D.S. No. 021-2017-SA which replaces Supreme Decree No. 017-2006-SA and repeals D.S. N ° 020-2015-SA established the moratorium on clinical studies in the pediatric…
Clinical Trials in Latin America – Challenges and Opportunities
Latin America has become a great ally for clinicians when developing Clinical Trials. This region provides many advantages and facilities other regions just can’t match. With over 20 countries spanning from Mexico in North America to Chile and Argentina in the South….
5 Barriers you’ll Have to Face while Diversifying Clinical Trials
Minority participation in clinical trials is an important topic in public health discussions. This representation touches on issues of equality and the elimination of disparities, which are core values of the field. The FDA Safety and Innovation Act introduced in 2012,…
6 Reasons to Diversify Clinical Trials
Starting from the fact that minorities account for fewer than 10 percent of patients enrolled in clinical trials. Health disparities and underrepresentation in clinical trials could become a serious issue in the upcoming years. FDA Regulations In 2012 Congress included Section…